Equillium Inc (EQ) Stock Price, Quote & News

Company Profile

Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need in the United States. Its lead product candidate is Itolizumab (EQ001), a first-in-class anti-CD6 immune-modifying monoclonal antibody, which is in phase 3 clinical trial to treat acute graft-versus-host disease, as well as completed Phase 1b clinical trial to treat systemic lupus erythematosus and lupus nephritis and...

Industry: Biotechnology

Sector: Healthcare

Phone: 858 240 1200

Website: www.equilliumbio.com

Address:

2223 Avenida De La Playa, Suite 105, La Jolla, United States

Finnisher2M Aug. 2 at 4:57 AM

$IXHL I love this stock. So much money you can make with this stock. This reminds me of $OCGN Stay patient and add little by little. It's a long way to go ❤️‍🔥 $LOBO $EQ $PHLT

1 · Reply

StockScanners Aug. 2 at 1:52 AM

$EQ keep watch if this holds above .50

1 · Reply

DayveTrader Aug. 2 at 1:25 AM

$EQ and back up next week

0 · Reply

Mervolo Aug. 2 at 12:11 AM

$LOBO 💪🏽 not great but looked like she was trying. $IXHL looks like she s coming out of zombie phase $RAYA grabbed a few just jn case. If next supports hit, we ll add more. But man, glad we didn t chase ,0850s cuz, homieeeeeee, fomo was real $MWYN i still like the name lols but what a fumble! $EQ was actually gonna jump in but spied $IXHL moving so took it instead. Was just cheaper 🤷‍♀️ Took too many trades today i think. Just kept seeing good setups but i suppose the job reports and my napping didnt help, lolz. But i did my part to chase! No risk it, no biscuit!

0 · Reply

XkaliburTrading Aug. 1 at 11:39 PM

$EQ $TNON $EZGO $LOBO $AACG GOOD FRIDAY it is LFG!!

0 · Reply

XkaliburTrading Aug. 1 at 11:37 PM

Good Friday everyone followers and Team! Hope you did amazing today as always. The Team and I was able to spot these at... (Part1) $EQ at 0.515 hod at 1.36 💯%'er+++ $TNON at 1.13 hod at 2.48 💯%'er 💪 $EZGO at 0.410 hod so far at 0.6895 🤷‍♂️ $LOBO at 0.440 hod at 1.27 💯%'er+++

1 · Reply

topstockalerts Aug. 1 at 11:33 PM

Top Gainers $LOBO $PHLT $FGF $EQ $TNON

0 · Reply

Ashtooon Aug. 1 at 11:13 PM

$RAYA $LOBO $EQ Watching until market close. Will announce top weekend buys around 7:45 pm est ;). The ones above are great but the Best Buy’s for the weekend are neither imo.

0 · Reply

Avior68 Aug. 1 at 11:04 PM

$EQ where is everbody..

1 · Reply

Mervolo Aug. 1 at 10:19 PM

$LOBO oooo ya gonna make me work late! $EQ still curious about $RAYA keeping an eye on Maybe markets a bit rattled a with trump firing that person cuz the jobs report came out worse than he wanted. Would instill even less confidence in usa markets so maybe asian plays are the way to go. Could be another taco trade setup if he backs off monday or over the weekend 🤷‍♀️

0 · Reply

Equillium Announces Multiple Poster Presentations Highlighting EQ504 at the Annual Meeting of The American Association of Immunologists

May 1, 2025, 8:00 AM EDT - 3 months ago

Equillium Announces New Aryl Hydrocarbon Receptor Modulator Program EQ504

Apr 24, 2025, 9:00 AM EDT - 3 months ago

Equillium Announces Feedback from the U.S. Food and Drug Administration

Mar 27, 2025, 11:16 AM EDT - 4 months ago

Penny Stock Equillium Falls After Itolizumab Treatment Fails To Show Improvement In Response Rates In Graft Versus Host Disease Patients

Mar 27, 2025, 7:00 AM EDT - 4 months ago

Equillium Announces Results of the Phase 3 EQUATOR Study of Itolizumab in First-Line Treatment of Patients with Acute Graft-Versus-Host Disease

Mar 27, 2025, 7:00 AM EDT - 4 months ago

Equillium Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate and Clinical Highlights

Feb 6, 2025, 8:00 AM EST - 6 months ago

Equillium Announces Positive Data from Phase 2 Study Evaluating Itolizumab in Patients with Moderate to Severe Ulcerative Colitis

Nov 13, 2024, 4:01 PM EST - 9 months ago

Equillium Reports Third Quarter 2024 Financial Results and Provides Corporate and Clinical Updates

Nov 13, 2024, 8:00 AM EST - 9 months ago

Equillium to Present at the Stifel Healthcare Conference

Nov 12, 2024, 8:00 AM EST - 9 months ago

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Oct 31, 2024, 7:00 AM EDT - 9 months ago

Equillium Maintains Rights to Itolizumab Following Ono Partnership

Oct 7, 2024, 8:00 AM EDT - 10 months ago

Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer

Sep 10, 2024, 8:00 AM EDT - 11 months ago

Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit

Sep 4, 2024, 8:00 AM EDT - 11 months ago

Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Aug 28, 2024, 8:00 AM EDT - 1 year ago

Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference

Aug 8, 2024, 4:01 PM EDT - 1 year ago

Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights

Aug 6, 2024, 8:00 AM EDT - 1 year ago

Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

Jul 18, 2024, 1:57 PM EDT - 1 year ago

Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Equillium to Participate in Upcoming Investor Conferences

Jun 12, 2024, 8:00 AM EDT - 1 year ago

Equillium to be included in the Russell Microcap® Index

Jun 4, 2024, 8:00 AM EDT - 1 year ago

Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata

May 29, 2024, 8:00 AM EDT - 1 year ago

Equillium to Present at the Jefferies Global Healthcare Conference

May 14, 2024, 8:00 AM EDT - 1 year ago

Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease

May 9, 2024, 4:01 PM EDT - 1 year ago

Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights

May 7, 2024, 8:00 AM EDT - 1 year ago

Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis

Mar 25, 2024, 4:01 PM EDT - 1 year ago

Equillium Reports on Fourth Quarter and Full Year 2023 Financial Results and Corporate and Clinical Highlights

Mar 22, 2024, 8:00 AM EDT - 1 year ago

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference and the LD Micro Invitational Conference

Dec 21, 2023, 8:00 AM EST - 1 year ago

Equillium Announces Update on Multi-Cytokine Inhibitors EQ101 & EQ102 in Development for Alopecia Areata and Celiac Disease

Nov 13, 2023, 9:00 AM EST - 1 year ago

Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology

Nov 8, 2023, 4:01 PM EST - 1 year ago

Equillium Reports Third Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Nov 6, 2023, 8:00 AM EST - 1 year ago

Equillium Announces Data from Phase 1b EQUALISE Study Presented at the 2023 Annual Meeting of the American Society of Nephrology

Oct 19, 2023, 8:00 AM EDT - 1 year ago

Equillium Announces Abstracts Accepted for Presentation at the 2023 Annual Meetings of the American Society of Nephrology and the American College of Rheumatology

Oct 16, 2023, 8:00 AM EDT - 1 year ago

Equillium Announces Preclinical Data from New Orally Deliverable Multi-Cytokine Inhibitor in Presentation at the 18th Annual Peptide Therapeutics Symposium

Oct 3, 2023, 8:00 AM EDT - 1 year ago

Equillium to Host Analyst & Investor Day

Oct 2, 2023, 8:00 AM EDT - 1 year ago

Equillium to Present at the JonesTrading 2023 Healthcare Summit

Sep 20, 2023, 8:00 AM EDT - 2 years ago

Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences

Aug 30, 2023, 8:00 AM EDT - 2 years ago

Equillium to Attend Wells Fargo Healthcare Conference & Present at H.C. Wainwright 25th Annual Global Investor Conference

Aug 9, 2023, 4:01 PM EDT - 2 years ago

Equillium Reports Second Quarter 2023 Financial Results and Provides Corporate and Clinical Updates

Aug 2, 2023, 4:00 PM EDT - 2 years ago

Equillium Announces $7.5 Million Share Repurchase Program

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Equillium to Present at the Jefferies Global Healthcare & LD Micro Invitational Conferences

May 12, 2023, 4:15 PM EDT - 2 years ago

Equillium: A Negative EV Biotech With Compelling Programs And Cash 'Til At Least 2025; Worth A Look

May 11, 2023, 4:01 PM EDT - 2 years ago

Equillium Reports First Quarter 2023 Financial Results and Provides Clinical Updates

Apr 24, 2023, 8:00 AM EDT - 2 years ago

Equillium Announces Poster Presentation at the Annual Meeting of the European Society for Blood and Marrow Transplantation

Mar 23, 2023, 4:01 PM EDT - 2 years ago

Equillium Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate & Clinical Development Updates

Mar 22, 2023, 8:00 AM EDT - 2 years ago

Equillium to Present at the H.C. Wainwright Autoimmune & Inflammatory Disease Conference

Feb 17, 2023, 8:00 AM EST - 2 years ago

Equillium Announces Oral Presentation at the Tandem Meetings of ASTCT and CIBMTR

Feb 7, 2023, 8:00 AM EST - 2 years ago

Equillium to Present at the SVB Securities Annual Global Healthcare Conference

Jan 13, 2023, 8:00 AM EST - 2 years ago

Equillium Announces Abstract Accepted for Oral Presentation at the Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR

Dec 23, 2022, 4:01 PM EST - 2 years ago

Equillium and Metacrine Mutually Agree to Terminate Definitive Merger Agreement

Finnisher2M Aug. 2 at 4:57 AM

$IXHL I love this stock. So much money you can make with this stock. This reminds me of $OCGN Stay patient and add little by little. It's a long way to go ❤️‍🔥 $LOBO $EQ $PHLT

1 · Reply

StockScanners Aug. 2 at 1:52 AM

$EQ keep watch if this holds above .50

1 · Reply

DayveTrader Aug. 2 at 1:25 AM

$EQ and back up next week

0 · Reply

Mervolo Aug. 2 at 12:11 AM

0 · Reply

XkaliburTrading Aug. 1 at 11:39 PM

$EQ $TNON $EZGO $LOBO $AACG GOOD FRIDAY it is LFG!!

0 · Reply

XkaliburTrading Aug. 1 at 11:37 PM

1 · Reply

topstockalerts Aug. 1 at 11:33 PM

Top Gainers $LOBO $PHLT $FGF $EQ $TNON

0 · Reply

Ashtooon Aug. 1 at 11:13 PM

$RAYA $LOBO $EQ Watching until market close. Will announce top weekend buys around 7:45 pm est ;). The ones above are great but the Best Buy’s for the weekend are neither imo.

0 · Reply

Avior68 Aug. 1 at 11:04 PM

$EQ where is everbody..

1 · Reply

Mervolo Aug. 1 at 10:19 PM

0 · Reply

Bullbear1010101 Aug. 1 at 10:19 PM

$EQ example of always buy on the way up . maybe a few pennies dip but dont buy in the last hour or s

0 · Reply

GoodRunner Aug. 1 at 10:03 PM

$EQ Boom it

1 · Reply

GoodRunner Aug. 1 at 10:02 PM

$EQ Took some $EQ for AH fun into close - $SPY $QQQ

0 · Reply

Love_To_Learn Aug. 1 at 10:02 PM

$EQ now be nice kids i need this 0.62 for beloved ok $PSTV 0.62 is completely separated from 0.59 which is true res

0 · Reply

Profit_lover Aug. 1 at 9:59 PM

$EQ Bid low get cheap shares make more profit or you can bid high and get fucked selling low

0 · Reply

smolcapcat Aug. 1 at 9:49 PM

$EQ rugged

0 · Reply

Bullbear1010101 Aug. 1 at 9:43 PM

$EQ what a disaster last few hours that's why i had lots of question marks

0 · Reply

Bullbear1010101 Aug. 1 at 9:42 PM

$EQ .665 out

0 · Reply

basereport Aug. 1 at 9:36 PM

🚀 Strongest stocks of the day Start tracking these today using our free stock screener: https://base.report/screener?filter_key=IJQVaoxW $LOBO $PHLT $EQ $FGF

0 · Reply

IntraTrades Aug. 1 at 9:32 PM

$FGF 90.36% $EQ 77.50% $LOBO 60.36% $EZGO 49.21% $SNSE 38.03%

0 · Reply

PaulLaurent Aug. 1 at 9:14 PM

📈🔎 Stocks with the Highest Relative Volume 🔎📈 $TNON $LOBO $PIFI $EQ $MWYN

0 · Reply

BreakoutBullz Aug. 1 at 9:07 PM

Have a great weekend, everyone!💰 Link in bio! See you on Monday at 4 AM ET! 🕓 Some of our plays from today! 🔥💰🎯 $LOBO $EQ $TNON $MWYN $BTAI

0 · Reply

Market Cap	13.97M
Revenue (ttm)	41.10M
Net Income (ttm)	-8.07M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-19.64%
Debt to Equity Ratio	0.00

Volume	144,211,688
Avg Vol	3,860,406
Day's Range	N/A - N/A
Shares Out	35.72M
Stochastic %K	35%
Beta	1.86
Analysts	Sell
Price Target	$4.50